Month: February 2018

China’s medical device industry market is 77 billion yuan and continues to grow by over 20 %

According to a report by the State Health Planning Commission, Chinese companies mostly occupy the middle and low prize tier of medical devices, wheres the top tier is dominated by foreign brands which are considered about 15 years ahead in development. However, Chinese companies are catching up in this segment as well and make quick […]

North China Pharmaceuticals increase operating income and total profit by 107% and 40%

The Hebei-based company is the only one in China which commercially uses three expression systems (mammalian cells, recombinant yeast, Escherichia coli). They are a leading producer of hepatitis B vaccine, G-CSF, GM-CSF, EPO and are the country’s major producer of recombinant human serum albumin. Currently a number of antibodies, fusion proteins, cytokines, vaccines and other […]

China’s R&D spending increased by 11.6 % in 2017

According to the National Bureau of Statistics, R&D spending rose 11.6 percent year-on-year to 1.75 trillion yuan (about 280 billion U.S. dollars) in 2017. The spending accounted for 2.12 percent of China’s gross domestic product. Chinese enterprises spent more than 1.37 trillion yuan on R&D last year, up 13.1 percent from 2016, while R&D spending […]

Balancing dietary amino acids contribute to weight loss

Increased body fat in humans is closely associated with obesity and diabetes. In swine production, increased body fat is inversely proportional to production efficiency and meat quality. Therefore, a better understanding of fat development is important for both humans and animals. Branched-chain amino acids containing leucine (Leu), isoleucine (Ile), and valine (Val), can act directly […]

Scroll to top